Pathway
|
Skin Aging
|
|
High Fat Diet Activates cAMP Related Exocytosis in Synapse and Endocrine Cell
|
|
Leptin and CCK8 Activate Nodose Ganglia Neuron
|
|
I-cell: CCK-8 Secretion and Regulation of Eating Behavior
|
|
Dopamine Receptors Signaling
|
|
Thyroid Hormones Common non-Genomic Effects in Hyperthyroidism
|
|
CXC Chemokine Receptor Signaling
|
|
CC Chemokine Receptor Signaling
|
|
Plasmin Effects in Inflammation
|
|
Platelet Activation via Adhesion Molecules
|
|
Proplatelet Maturation
|
|
Toll-like Receptor Independent Sterile Inflammation
|
|
Eat me Signal: Apoptotic Cell Induces Phagocytosis
|
|
Eicosanoids in Myeloid Cell Activation
|
|
Eosinophil Activation
|
|
Mast-Cell Activation without Degranulation
|
|
Mast-Cell Activation without Degranulation through KIT/F2R Signaling
|
|
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling
|
|
CD16/CD14 Proinflammatory Monocyte Activation
|
|
anti-Inflammatory Function of Macrophage M2 Lineage
|
|
Neutrophil Chemotaxis
|
|
Vascular Smooth Muscle Cell/Pericyte Migration and Proliferation
|
|
Vascular Endothelial Cell Activation by Blood Coagulation Factors
|
|
Vascular Endothelial Cell Activation by Growth Factors
|
|
Vascular Endothelial Cell Permeability Activation
|
|
Potassium Flux Regulation
|
|
GFs/TNF -> Ion Channels
|
|
Nociception Expression Targets Signaling
|
|
Vascular Motility
|
|
Ca2+ Flux Regulation
|
|
ADRA2C/ADRB2 -> Vasoconstriction
|
|
ADRA2C/ADRB2 -> Synaptic Endocytosis
|
|
ADRB1 -> Prostaglandin Generation
|
|
DRD2 Expression Targets
|
|
DRD2 -> TRPC1 Transcription
|
|
DRD2/4 -> Membrane Transport
|
|
CHRM1 -> IL2 Production
|
|
OPRK -> Pain Perception
|
|
IL6 Expression Targets -> Nociception
|
|
GABA(B)R -> Postsynaptic Inhibition
|
|
NTRK1/2/3 -> Acetylcholine Production
|
|
EPHB -> NMDA Receptor Activation
|
|
Vitamine D Deficite and Dentin Formation
|
|
G0/G1 Phase Transition
|
|
Adherens Junction Assembly (Nectin)
|
|
Focal Junction Assembly
|
|
Adherens Junction Assembly (Cadherins)
|
|
Proteins Involved in Arterial Hypertension
|
|
Endothelin Signaling in Arterial Hypertension
|
|
Arterial Hypertension
|
|
Endothelial Cell Dysfunction in Arterial Hypertension
|
|
Aldosterone Synthesis Chronic Regulation
|
|
Smooth Muscle Cell Dysfunction in Arterial Hypertension
|
|
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis)
|
|
Proteins Involved in Pulmonary Hypertension
|
|
Endothelial Cell Dysfunction in Pulmonary Hypertension
|
|
Myocardial Remodeling
|
|
Proteins Involved in Myocarditis
|
|
Vascular Reactivity in Raynaud Disease
|
|
Melanoma
|
|
Proteins Involved in Melanoma
|
|
Vitiligo
|
|
Apoptosis of Melanocyte in Vitiligo
|
|
Macrophage Function in Diabetes Mellitus Type 1
|
|
Treg-Cell Activation in Diabetes Mellitus
|
|
Tubular Cell Dysfunction in Progressive Diabetic Nephropathy
|
|
Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy
|
|
Mesangial Cell Dysfunction in Diabetic Nephropathy
|
|
Proliferative Diabetic Retinopathy
|
|
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease
|
|
Hyperparathyroidism, Neonatal Severe
|
|
Bone Remodeling in Hyperthyroidism
|
|
KISS1 Production Impairment in Hypogonadotropic hypogonadism
|
|
Hypoparathyroidism, Primary
|
|
Proteins Involved in Obesity
|
|
Enterocyte Mediated Mucosal Damage in Celiac Disease
|
|
Proteins Involved in Colorectal Neoplasms
|
|
Metastatic Colorectal Cancer
|
|
GUCY2C Signaling in Colorectal Cancer
|
|
OipA Signaling in Helicobacter Pylori Infection
|
|
CagA Phosphorylation Independent Signaling
|
|
CagA Phosphorylation Dependent Signaling
|
|
B-Cell Acute Lymphoblastic Leukemia
|
|
B-Cell Chronic Lymphocytic Leukemia
|
|
Chronic Myeloid Leukemia
|
|
Proteins Involved in Chronic Myeloid Leukemia
|
|
Follicular Lymphoma
|
|
Hodgkin Lymphoma
|
|
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
|
|
Osteoclast Activation in Multiple Myeloma
|
|
IL6/IGF1/VEGFA Signaling in Multiple Myeloma
|
|
Multiple Myeloma
|
|
Proteins Involved in Hepatocellular Carcinoma
|
|
Hepatocellular Carcinoma
|
|
Growth Factor Signaling in Hepatocellular Carcinoma
|
|
Proteins Involved in Pancreatic Cancer
|
|
Pancreatic Ductal Carcinoma
|
|
Growth Factor Signaling in Pancreatic Neoplasms
|
|
Pancreatic Neuroendocrine Tumors
|
|
Eosinophil Activation and Degranulation in Asthma
|
|
Airway Smooth Muscle Cell High Rate Proliferation
|
|
IgE Induces Airway Smooth Muscle Cell Proliferation
|
|
Airway Smooth Muscle Cell Contraction
|
|
Mast-Cell Related Chemokines Signaling in Asthma
|
|
Osteoclast Activation in Gout
|
|
Osteoclast Activation in Psoriatic Arthritis
|
|
Synovial Fibroblast Proliferation in Rheumatoid Arthritis
|
|
Osteoclast Activation in Rheumatoid Arthritis
|
|
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma
|
|
Skin Fibrosis
|
|
WHIM Syndrome
|
|
CCR5 Signaling in Macrophages
|
|
Macrophage Survival through CCR5 and CXCR4 Mediated Signaling
|
|
Estrogen Effects on Pregnancy Gingivitis
|
|
Hereditary Hemorrhagic Telangiectasia
|
|
Cowden Syndrome
|
|
Glutamate Toxiicity Effects on Striatum Medium Spiny Neurons in Hantington's Disease
|
|
Ca2+ Overload in Muscular Dystrophies
|
|
Muscular Dystrophies
|
|
Dystrophin Glycoprotein Complex Signaling in Muscular Dystrophies
|
|
Proteins Involved in Osteopetrosis
|
|
Proteins Involved in Osteoporosis
|
|
Osteoclast Activation in Postmenopause
|
|
Proteins Involved in Alzheimer's Disease
|
|
Proteins Involved in Epilepsy
|
|
BDNF Upregulation Triggered by Seizures
|
|
HMGB1 and IL1B in Neuronal Hyperexcitation
|
|
Glioblastoma, Primary
|
|
Medulloblastoma
|
|
Growth Factor Signaling in Neuroblastoma
|
|
Neuroblastoma
|
|
Proteins Involved in Neuroblastoma
|
|
Microglia and Motor Neuron Interaction Dysregulation
|
|
SPP1 Induced Survival of Myelin Specific T-Cells in Multiple Sclerosis
|
|
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway
|
|
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway
|
|
ERBB/VEGFR/Akt Signaling in Breast Cancer
|
|
IGF1R/AKT Signaling in Breast Cancer
|
|
ESR1/ERBB Positive Luminal Breast Cancer
|
|
Proteins with Altered Expression in Breast Cancer
|
|
Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway
|
|
Breast Cancer
|
|
ESR1 Signaling in Breast Cancer
|
|
Endometrial Cancer
|
|
Endometrioid Endometrial Cancer
|
|
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer
|
|
Angiogenesis in Endometriosis
|
|
Coagulation Factors and PAR1/2 Receptors (F2R/F2RL1) in Endometriosis
|
|
Proteins Involved in High-Grade Serous Ovarian Carcinoma
|
|
Endometrioid Ovarian Carcinoma
|
|
Proteins Involved in Endometrioid Ovarian Carcinoma
|
|
Clear Cell Ovarian Carcinoma
|
|
Proteins Involved in Mucinous Ovarian Carcinoma
|
|
High-Grade Serous Ovarian Carcinoma
|
|
Low-Grade Serous Ovarian Carcinoma
|
|
Proteins Involved in Low-Grade Serous Ovarian Carcinoma
|
|
Ovarian Cancer
|
|
Proteins Involved in Clear Cell Ovarian Carcinoma
|
|
Mucinous Ovarian Carcinoma
|
|
MIF Role in Cholesteatoma
|
|
Cholesteatoma
|
|
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes
|
|
Androgen Receptor Coregulator ARA55 (TGFB1I1) in Prostate Cancer
|
|
Prostate Cancer
|
|
TRPM8 Effects in Prostate Cancer (Hypothesis)
|
|
Proteins Involved in Prostate Cancer
|
|
Ca2+ Toxicity in Lens Cells
|
|
Proteins Involved in Cataract
|
|
VEGFA in Neovascular Glaucoma
|
|
Proteins Involved in Noise-Induced Hearing Loss
|
|
Alveolar Macrophages Dysfunction in COPD
|
|
VEGFA Low Expression Level in Chronic Bronchitis
|
|
VEGFA High Expression Level in Pulmonary Emphysema
|
|
T-Cell Cytotoxic Activation
|
|
Alveolar Epithelial Cell Dysfunction in COPD
|
|
Proteins Involved in Polycystic Kidney Disease
|
|
Proteins Involved in Glomerulonephritis
|
|
Plasmin Role in Glomerulonephritis
|
|
Endothelial Cell Dysfunction in Glomerulonephritis
|
|
Mesangial Cell Dysfunction in Glomerulonephritis
|
|
Interstitial Fibroblasts in Pyelonephritis
|
|
Sertoli Cells Dysfunction Causes Male Infertility
|
|
CD157/ITGB2 Signaling in Myeloid Cell
|
|
CD38 -> cADPR/Calcium Signaling
|
|
ANGPT1 -> CREB/CREBBP Expression Targets
|
|
ANGPT2 -> AP-1/CREBBP/MYC Expression Targets
|
|
AREG -> NFATC Expression Target
|
|
AREG -> CREB/CREBBP Expression Targets
|
|
AREG -> NCOR2 Expression Targets
|
|
AREG -> CTNN Expression Targets
|
|
AREG -> HIF1A Expression Targets
|
|
AREG -> STAT Expression Targets
|
|
AREG -> AP-1 Expression Targets
|
|
Noradrenaline/Gs Expression Targets
|
|
Epinephrine/Gs Expression Targets
|
|
Acetylcholine Expression Targets
|
|
Dopamine/Gi Expression Targets
|
|
Aryl Hydrocarbon Receptor Genomic and non-Genomic Signaling
|
|
BTC -> NFATC Expression Targets
|
|
BTC -> AP-1/ATF/CREB Expression Targets
|
|
BTC -> CTNN Expression Targets
|
|
BTC -> STAT Expression Targets
|
|
AGTR1 -> ARRB1/ARRB2 Signaling
|
|
INSR -> ARRB2/AKT/SRC Signaling
|
|
ARRB1/ARRB2 non-CanonicalSignaling and HedgehogFamily
|
|
CD72 -> NF-kB Expression Targets
|
|
CD8 -> NF-kB Expression Targets
|
|
CD80 -> NFATC Expression Targets
|
|
CD86 -> NFATC Expression Targets
|
|
EGF -> CTNN Expression Targets
|
|
EGF -> HIF1A Expression Targets
|
|
EGF -> AP-1/ATF Expression Targets
|
|
EGF -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
EGF -> MEF/MYOD/NFATC Expression Targets
|
|
EGF -> TP53 Expression Targets
|
|
EGF -> NCOR2 Expression Target
|
|
EGF -> STAT Expression Targets
|
|
EGFR -> NCOR2 Signaling
|
|
EGFR/ERBB3 -> MEF/MYOD/NFATC/MYOG Signaling
|
|
EGFR -> CTNND Signaling
|
|
EGFR/ERBB2 -> TP53 Signaling
|
|
EGFR/ERBB2 -> CTNNB Signaling
|
|
EGFR/ERBB2 -> HIF1A Signaling
|
|
EGFR -> AP-1/ATF2 Signaling
|
|
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling
|
|
EGFR/ERBB -> STAT Signaling
|
|
EREG -> CREB Expression Target
|
|
EREG -> CTNNB/CTNND Expression Target
|
|
EREG -> STAT Expression Targets
|
|
EREG -> HIF1A Expression Target
|
|
EREG -> AP-1/ATF Expression Targets
|
|
Erythropoietin -> AP-1/MYC/CREB Expression Targets
|
|
F2 -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
F2 -> STAT1/NF-kB Expression Targets
|
|
PLG -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
PLG -> STAT1/NF-kB Expression Targets
|
|
FGF9 -> AP-1/CREB/MYC Expression Targets
|
|
FGF10 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF2 -> STAT Expression Targets
|
|
FGF1 -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
FGF1 -> NCOR2 Expression Target
|
|
FGF8 -> AP-1/CREB/MYC Expression Targets
|
|
FGF10 -> STAT Expression Targets
|
|
FGF18 -> AP-1/CREB Expression Targets
|
|
FGF23 -> NCOR2 Expression Targets
|
|
FGF1 -> STAT Expression Targets
|
|
FGF2 -> NCOR2 Expression Targets
|
|
FGF4 -> AP-1/MYC Expression Targets
|
|
FGF7 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF2 -> AP-1/CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
FGFR1 -> STAT Signaling
|
|
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling
|
|
Glutamate/Gq Expression Targets
|
|
HBEGF -> STAT Expression Targets
|
|
HBEGF -> AP-1/ATF Expression Targets
|
|
HBEGF -> TP53 Expression Targets
|
|
HBEGF -> HIF1A Expression Targets
|
|
HBEGF -> MEF/MYOD Expression Target
|
|
HBEGF -> CREB/MYC Expression Targets
|
|
HGF -> STAT Expression Targets
|
|
HGF -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
HGFR -> STAT Signaling
|
|
HGFR -> AP-1/CREB/MYC Signaling
|
|
EGFR Transactivation in Cancer and Non-Cancer Cells
|
|
TAM Receptor Signaling Activation in Cancer
|
|
Receptors and Adaptor Proteins Activated in Cancer
|
|
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling
|
|
G0/G1 Cell Cycle Phase Transition Activation in Cancer
|
|
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis
|
|
STAT3 Inhibits Maturation of Dendritic Cells and Facilitates Cancer Progression
|
|
VEGFA Dependent Angiogenesis in Cancer
|
|
VEGF Independent Angiogenesis in Cancer
|
|
Integrins in Cancer Cell Motility, Invasion and Survival
|
|
Proteins with Altered Expression in Cancer Metastases
|
|
Epithelial to Mesenchymal Transition in Cancer: Overview
|
|
Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival
|
|
CDH2 Activation Promotes Cancer Cell Migration and Survival
|
|
CFL1 in Cancer Cell Motility
|
|
Invadopodia Formation in Cancer Cells
|
|
Myeloid Derived Suppressor Cells in Cancer Immune Escape
|
|
IGF1 -> MEF/MYOD/MYOG Expression Targets
|
|
IGF2/MEF/MYOD Expression Targets
|
|
IGF2 -> HIF1A/MYC Expression Targets
|
|
IGF1 -> ELK/SRF/HIF1A/MYC/SREBF Expression Targets
|
|
Insulin -> MEF/MYOD Expression Targets
|
|
Insulin -> ELK/SRF/HIF1A/MYC/SREBF Expression Targets
|
|
PECAM -> STAT Signaling
|
|
IGF1R -> ELK/SRF/HIF1A/MYC/SREBF Signaling
|
|
IGF1R -> MEF/MYOD/MYOG Signaling
|
|
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling
|
|
MacrophageR -> CEBPB -> NF-kB Signaling
|
|
CTGF -> AP-1/CREB/MYC Expression Targets
|
|
CTGF -> NCOR2 Expression Target
|
|
ICAM1 Expression Targets
|
|
Fibrinogen Expression Targets
|
|
IL6ST -> STAT5B Signaling
|
|
IL6 Expression Targets
|
|
IL16-> ATF/CREB/CREBBP Expression Target
|
|
Morphine Expression Targets
|
|
Proteins/Ions Transporters -> Expression Targets in Lymphoid System and Blood
|
|
NRG1 -> MEF/MYOD Expression Targets
|
|
NRG1 -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
NRG1 -> TP53 Expression Target
|
|
NRG1/Catenin Expression Targets
|
|
NRG1 -> STAT Expression Targets
|
|
NRG1 -> AP-1/ATF Expression Targets
|
|
NRG1 -> HIF1A Expression Target
|
|
NGF -> SMAD3/NF-kB Expression Targets
|
|
NGF -> AP-1/TP53/MYC Expression Targets
|
|
NGF -> FOXO/MYCN/ELK-SRF Expression Targets
|
|
BDNF Expression Targets
|
|
NGF -> CREB/CEBPB/MEF2A Expression Targets
|
|
Adenosine Expression Targets
|
|
PDGFC -> STAT Expression Target
|
|
PDGFB -> AP-1/CREB/MYC Expression Target
|
|
PDGFC -> CREB Expression Target
|
|
PDGFD -> AP-1 Expression Targets
|
|
PDGFD -> STAT Expression Targets
|
|
PDGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PDGF -> STAT Expression Targets
|
|
PDGFB -> STAT Expression Target
|
|
KIT -> MITF Signaling
|
|
PDGFR -> STAT Signaling
|
|
CSF2 -> STAT Signaling
|
|
PDGFR -> AP-1/MYC Signaling
|
|
AVP/Gs -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
POMC Expression Targets
|
|
AVP/Gs -> MEF/MYOD/NFATC/MYOG Expression Targets
|
|
AVP/Gq -> STAT Expression Targets
|
|
IFNA1/Gq Expression Targets
|
|
AVP/Gs -> STAT Expression Targets
|
|
AVP/Gq -> MEF/MYOD/NFATC/MYOG Expression Targets
|
|
AVP/Gq -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
PDCD1 -> ATF/CREB/CREBBP Expression Targets
|
|
AngiopoietinR -> AP-1 Signaling
|
|
EphrinB -> Cytoskeleton Signaling
|
|
GDNF -> HSF1 Signaling
|
|
EphrinB -> MAPK/JUN/FOS Signaling
|
|
NTRK -> FOXO/MYCN Signaling
|
|
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling
|
|
CSF1 -> STAT Expression Targets
|
|
GAS6 -> AP-1/CREB Expression Targets
|
|
FIGF -> AP-1 Expression Target
|
|
FIGF -> NCOR2 Expression Target
|
|
KITLG -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
GDNF -> HSF1 Expression Targets
|
|
CSF1 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FLT3LG -> AP-1/CREB/CREBBP Expression Targets
|
|
Ras-GRF Regulation Signaling
|
|
Androgen Receptor non-Genomic Signaling
|
|
FOXO1 Signaling
|
|
MERTK Signaling
|
|
Ras-GAP Regulation Signaling
|
|
PI3K/RAC1 Signaling
|
|
VEGF Signaling
|
|
Estrogens/ESR1 non-Genomic Signaling
|
|
EGFR Signaling
|
|
ERK5/MAPK7 Signaling
|
|
ERK/MAPK Canonical Signaling
|
|
TCR -> CREB/CREBBP/ATF Expression Targets
|
|
TCR -> NFAT Expression Targets
|
|
TCR -> AP-1 Expression Targets
|
|
TGFA -> STAT Expression Targets
|
|
TGFA -> CTNNB/CTNND Expression Targets
|
|
TGFA -> TP53 Expression Targets
|
|
TGFA -> HIF1A Expression Targets
|
|
TGFA -> MEF/MYOD/NFATC Expression Targets
|
|
TGFA/AP-1/ATF Expression Targets
|
|
TGFA -> CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
CD40LG -> NF-kB/ELK/SRF -> CREB/NFATC Expression Targets
|
|
TNFSF13B Expression Targets
|
|
TNFRSF5/13B -> NFATC1 Signaling
|
|
Thrombopoietin -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy
|
|
VEGFA -> ATF/CREB/ELK-SRF Expression Targets
|
|
VEGFC -> CTNNB Expression Target
|
|
VEGFA -> NFATC Expression Targets
|
|
VEGFA -> STAT Expression Targets
|
|
VEGFC -> ATF Expression Target
|
|
VEGFA -> AP-1/CREBBP/MYC Expression Targets
|
|
VEGFA -> CTNNB/CTNND Expression Targets
|
|
VEGFA -> NCOR2 Expression Target
|
|
VEGFR -> CTNND Signaling
|
|
VEGFR -> CTNNB Signaling
|
|
VEGFR -> NFATC Signaling
|
|
VEGFR -> STAT Signaling
|
|
VEGFR -> AP-1/CREB/MYC Signaling
|
|
VEGFR -> ATF/CREB/ELK-SRF Signaling
|
|
WNT5A Expression Targets
|
|
Model of PPARG signaling in psoriasis
|
|
PPARG negative regulators and targets
|
|
Model of PPARG related pathways in psoriasis (short version)
|
|
1_Osteoclast-mediated bone resorption in postmenopausal women
|
|
2_Osteoblast-mediated bone demineralization
|
|
3_The role of interstitial fibroblasts in pyelonephritis
|
|
3_Mesangial cell dysfunction in glomerulonephritis
|
|
1_Local estrogen production stimulates ectopic endometrium proliferation
|
|
3_Enhanced angiogenesis in endometriosis
|
|
1_Disruption of luteinizing hormone and follicle-stimulating hormone secretion in PCOS
|
|
1_Endothelial cells stimulate vasoconstriction and thrombosis in pulmonary hypertension
|
|
1_Cigarette smoke causes dysfunction and production of inflammatory mediators in alveolar epithelial cells
|
|
3_Role of alveolar macrophages in pulmonary tissue destruction in COPD
|
|
2_1_Eosinophilia and neutrophilia in asthma: eosinophil migration and activation
|
|
4_1_Airway smooth muscle cells contraction
|
|
4_2_Airway smooth muscle cells proliferation and airway tissue remodeling
|
|
1_CD4+ T cell and epithelial cell response in celiac disease
|
|
2_1_General pathways of thyroid hormone signaling
|
|
drug-target moltransport
|
|
Model of PPARG signaling in psoriais (tested)
|
|
mapk1 protein modificators
|